4.1 Upper Airway Diseases & Gastroesophageal Reflux

4.1 Upper Airway Diseases & Gastroesophageal Reflux

Core Concept: The upper and lower respiratory tracts constitute an anatomical, physiological, and immunological continuum termed the "united airway." Pathological processes occurring above the vocal cords—including allergic rhinitis and chronic rhinosinusitis—directly amplify lower airway inflammation, while gastroesophageal reflux mechanically and reflexively provokes bronchospasm. Optimizing asthma control requires identifying and aggressively co-managing these upper airway and gastrointestinal comorbidities.

Asthma rarely exists in clinical isolation. In both pediatric and adult populations, comorbid upper airway diseases and gastrointestinal disorders significantly alter the clinical course of asthma, driving persistent symptoms, frequent nocturnal awakenings, blunted responses to inhaled therapies, and increased healthcare utilization. The Certified Asthma Educator must approach asthma not as an isolated lower airway condition, but as the bronchial manifestation of wider systemic and mucosal pathology.

---

The United Airway Concept: Anatomy, Immunology, and Neural Crosstalk

The "one-airway-one-disease" or "united airway" paradigm recognizes that the respiratory tract from the nasal vestibule to the terminal bronchioles functions as an integrated biological unit. Morphologically, both upper and lower airways are lined by pseudostratified ciliated columnar respiratory epithelium interspersed with mucus-secreting goblet cells and supported by a vascularized submucosa containing dendritic cells, mast cells, and lymphoid aggregates.

Four distinct, interconnected pathophysiological mechanisms link upper airway pathology directly to lower airway bronchial hyperresponsiveness:

1. Systemic Hematogenous Mediator Trafficking: Allergic or non-allergic inflammation in the nasal mucosa and paranasal sinuses does not remain compartmentalized. Activated nasal epithelial cells and mucosal dendritic cells release alarmins (Thymic Stromal Lymphopoietin [TSLP], IL-25, IL-33) and Type 2 cytokines (IL-4, IL-5, IL-13) into the systemic venous circulation. Circulating IL-5 travels to the bone marrow, stimulating eosinophilopoiesis and the mobilization of immature CD34+ eosinophil/basophil progenitors. These primed effector cells migrate through systemic circulation and home into the bronchial submucosa, drastically escalating baseline bronchial hyperresponsiveness (BHR) even in the absence of direct lower airway allergen exposure.
2. The Nasobronchial Neural Reflex: The nasal mucosa is richly innervated by sensory afferent fibers of the ophthalmic and maxillary divisions of the trigeminal nerve (cranial nerve V), while the bronchial tree is innervated by parasympathetic efferent fibers of the vagus nerve (cranial nerve X). Chemical irritation, cold dry air, or inflammatory mediators in the upper nasal passages stimulate trigeminal sensory endings. Afferent impulses ascend to the brainstem reticular formation, synapsing with the dorsal motor nucleus of the vagus nerve. Efferent parasympathetic firing triggers acetylcholine release at bronchial M3 muscarinic receptors, causing acute smooth muscle bronchoconstriction and submucosal gland hypersecretion.
3. Post-Nasal Drainage and Pharyngeal Aspiration: Chronic rhinosinusitis and allergic rhinitis produce copious purulent or mucopurulent secretions laden with cytotoxic eosinophil granule proteins (Major Basic Protein [MBP], Eosinophil Cationic Protein [ECP]), inflammatory leukotrienes, and bacterial antigens. Gravitational drainage of these secretions into the hypopharynx and laryngeal inlet during sleep induces chronic mechanical irritation of sensory cough receptors, reflex bronchospasm, and microaspiration that directly damages bronchial epithelial tight junctions.
4. Loss of Nasal Conditioning and Obligate Mouth Breathing: The nasal turbinates provide critical physiologic conditioning, warming inspired air to 37°C (98.6°F), humidifying it to 100% relative humidity, and filtering airborne particulates larger than 5 to 10 µm. Chronic nasal obstruction from mucosal edema or polyposis forces obligate mouth breathing. Unconditioned, cold, dry, allergen-dense air enters the lower respiratory tract directly, triggering airway mucosal dehydration, hyperosmolar stress, mast cell degranulation, and exercise- or cold-induced bronchospasm.

---

Upper Airway & GI Comorbidity Matrix

---

Allergic Rhinitis & Chronic Rhinosinusitis: Nuances for Asthma Education

Allergic rhinitis is the single most common comorbid condition in asthma, affecting over 80% of individuals with allergic asthma and more than 60% of non-allergic asthmatics. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines stress that allergic rhinitis and asthma must be evaluated and managed as a single, combined disease entity.

Distinguishing CRSwNP from CRSsNP

Chronic rhinosinusitis (CRS) is clinically diagnosed when an individual experiences at least two of the following four cardinal symptoms for ≥12 consecutive weeks, with at least one symptom being nasal obstruction or nasal discharge:

1. Nasal blockage, obstruction, or congestion
2. Anterior or posterior rhinorrhea (mucopurulent drainage)
3. Facial pain, pressure, or fullness
4. Reduction or complete loss of smell (hyposmia or anosmia)

In asthma, differentiating CRSwNP from CRSsNP is paramount:

• CRSwNP (with polyps): Dominated by Type 2 eosinophilic inflammation with high tissue eosinophilia, elevated IL-5 and IL-13, and intense tissue edema. Nasal polyps arise primarily from the middle meatus and ethmoid sinuses, appearing on anterior rhinoscopy as smooth, translucent, gelatinous, insensitive, non-vascular grape-like structures. CRSwNP is extraordinarily common in severe adult-onset asthma and serves as a cardinal feature of Aspirin-Exacerbated Respiratory Disease (AERD). It responds robustly to Type 2-targeted biologic agents (e.g., dupilumab, mepolizumab, omalizumab).
• CRSsNP (without polyps): Frequently characterized by non-Type 2 or mixed inflammation (neutrophils, Th1/Th17 cytokines, TGF-beta-mediated collagen deposition and subepithelial fibrosis). Patients complain more bitterly of persistent facial pressure and pain, and therapy relies primarily on mechanical saline irrigation and topical anti-inflammatory sprays.

Intranasal Corticosteroid (INCS) Delivery Technique

Intranasal corticosteroids (fluticasone propionate, fluticasone furoate, mometasone furoate, budesonide, triamcinolone acetonide) are the absolute first-line pharmacological treatment for both allergic rhinitis and CRSwNP. Correct administration technique directly dictates clinical efficacy and prevents adverse events.

Step-by-Step INCS Teaching Protocol (Cross-Hand Technique):
1. Blow nose gently to clear mucus before administration.
2. Shake the medication bottle gently; prime if unused or expired.
3. Tilt head slightly FORWARD (look at feet/floor, NOT up at ceiling).
4. Hold spray bottle with OPPOSITE hand to OPPOSITE nostril:
   - Right hand holds bottle to spray LEFT nostril.
   - Left hand holds bottle to spray RIGHT nostril.
5. Insert nozzle tip just inside nostril, aiming OUTWARD and BACKWARD toward the lateral eye / ear.
6. Spray while sniffing GENTLY (do not snort deeply into the throat).
7. Exhale through mouth; do NOT blow nose immediately afterward.

Critical Educator Warning on Septal Injury: Directing the spray nozzle medially toward the nasal septum repeatedly deposits corticosteroid onto Kiesselbach's plexus (an area of delicate, anastomosing superficial arterial vessels on the anterior cartilaginous septum). This causes localized mucosal atrophy, recurring epistaxis (nosebleeds), painful septal ulcerations, and, in severe cases, irreversible nasal septal perforation. Cross-hand administration physically prevents the user from aiming at the septum.

---

Gastroesophageal Reflux Disease (GERD) & Silent LPR

Gastroesophageal reflux disease affects 30% to 70% of individuals with asthma. The relationship is complex and reciprocal: reflux provokes bronchospasm, while asthma exacerbations—through hyperinflation, flattened diaphragmatic mechanics, increased negative intrathoracic inspiratory pressure (-30 to -50 cm H2O), and coughing—mechanically overcome the lower esophageal sphincter, forcing gastric contents upward.

Two Pathophysiological Mechanisms of Reflux-Induced Bronchospasm

1. The Vagal Esophagobronchial Reflex: The lower third of the esophagus and the bronchial tree share embryonic foregut lineage and dual vagal innervation. Influx of hydrochloric acid (pH < 4.0), pepsin, or bile salts into the distal esophagus stimulates intraepithelial acid-sensitive vagal C-fibers and transient receptor potential vanilloid-1 (TRPV1) receptors. Afferent signals ascend via the vagus nerve to the medulla, provoking reflex vagal parasympathetic efferent outflow to bronchial smooth muscle. Acetylcholine binds to smooth muscle M3 muscarinic receptors, precipitating acute, widespread bronchoconstriction without requiring any fluid to enter the airway.
2. Direct Microaspiration: Retrograde transit of liquid or aerosolized gastric juice past an incompetent upper esophageal sphincter (UES) allows droplets of acid, pepsin, and trypsin to be aspirated into the posterior larynx, vocal cords, and tracheobronchial tree. Hydrochloric acid causes chemical deep-tissue caustic burns, desquamating the ciliated epithelium, stripping surfactant, and inducing neurogenic inflammation through the release of substance P, calcitonin gene-related peptide (CGRP), and neurokinin A. Inhaled pepsin remains enzymatically active within the bronchial mucosa, digesting extracellular matrix proteins and provoking intense airway hyperresponsiveness.

Asthma Pharmacotherapy That Exacerbates Reflux

Asthma educators must recognize that common asthma medications can aggravate underlying GERD:

• Beta-2 Adrenergic Agonists (SABA and LABA): While relaxing bronchial smooth muscle, beta-2 agonists also relax the smooth muscle of the lower esophageal sphincter (LES), lowering basal resting sphincter pressure and increasing the frequency of transient LES relaxations.
• Theophylline (Methylxanthines): Potently relaxes LES smooth muscle while simultaneously stimulating parietal cell gastric acid secretion via cyclic adenosine monophosphate (cAMP) accumulation.
• Systemic Corticosteroids: Oral corticosteroids increase gastric acidity, impair protective gastric mucosal prostaglandin synthesis, and delay gastric emptying.

Identifying Asymptomatic ("Silent") GERD and LPR

Up to 50% to 60% of patients with asthma and documented pathological reflux have NO classical gastrointestinal symptoms (no heartburn, no acid indigestion). Instead, reflux presents exclusively with extra-esophageal and respiratory complaints termed Laryngopharyngeal Reflux (LPR) or Silent GERD:

• Paroxysmal nocturnal coughing fits awakening the patient 1 to 3 hours after falling asleep
• Morning hoarseness, dysphonia, or raspy voice upon waking
• Chronic, repetitive throat clearing and sticky hypopharyngeal mucus
• Globus pharyngeus (sensation of a constant "lump" or constriction in the throat)
• Postprandial coughing or wheezing, especially after large, rich, or acidic meals
• Unexplained asthma symptoms that remain refractory to step 4 or 5 controller therapy

Evidence-Based Non-Pharmacological Counseling

Asthma educators play an indispensable role in counseling patients on non-pharmacological reflux mitigation, which significantly reduces nocturnal bronchospasm:

1. Elevate the Head of the Bed 6 to 8 Inches (15 to 20 cm): The patient must elevate the entire head of the bed using solid wooden/plastic bed risers placed securely beneath the front headboard posts, or sleep on a medical-grade, rigid, inclined foam wedge beneath the upper mattress. Crucial Misconception: Stacking ordinary pillows under the head is completely ineffective and harmful; bending at the waist or neck flexes the torso, increases intra-abdominal pressure against the gastric fundus, and promotes retrograde acid transit.
2. The 3-Hour Pre-Bed Fasting Rule: Enforce strict cessation of all solid foods, caloric beverages, and snacks at least 3 hours before reclining. Going to sleep with an empty stomach ensures that primary gastric digestive acid secretion and gastric emptying are complete, eliminating the reservoir for nocturnal reflux.
3. Dietary Modification: Instruct patients to eliminate foods that pharmacologically decrease LES basal resting pressure or stimulate gastric acid production:
   • Caffeine (coffee, tea, energy drinks) and decaffeinated coffee (contains acid-stimulating chlorogenic acids)
   • Chocolate (contains theobromine, which potently relaxes the LES)
   • Peppermint and spearmint (volatile oils that relax esophageal smooth muscle)
   • High-fat, fried, and greasy foods (slow gastric emptying and prolong gastric distension)
   • Acidic foods: citrus fruits/juices, tomato-based sauces, and vinegar
   • Carbonated sodas and seltzers (induce gastric belching and transient LES openings)
   • Alcohol and tobacco/nicotine (nicotine directly relaxes the LES sphincter)
4. Weight Loss: In overweight and obese individuals, increased intra-abdominal visceral adiposity exerts continuous mechanical compression on the stomach, forcing the gastroesophageal junction upward (promoting hiatal hernia formation and reflux). Weight loss of 5% to 10% directly reduces intra-abdominal pressure and nocturnal reflux episodes.